Aditxt stock.

Loma Linda, CA, July 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) ... each unit consisting of one share of common stock, one Series A ...

Aditxt stock. Things To Know About Aditxt stock.

Aditxt Inc ( ADTX) is up 130.00% today. ADTX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on ADTX! ADTX stock closed at $3.50 and is up $4.55 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.On April 3, 2023, Aditxt subsidiary, Pearsanta, Inc. (“Pearsanta”) submitted a bid to acquire substantially all of Lucira Health Inc.’s (“Lucira”) assets, which included Lucira Connect and FDA-approved at-home combination COVID-19 and flu tests. At the bankruptcy auction, which was held on April 6, 2023, Pearsanta was chosen as the ...All values updated annually at fiscal year end. Earnings Per Share -595.50. Sales 20.14. Tangible Book Value 47.38. Operating Profit -537.79. Working Capital 10.22. Long Term Liabilities 17.51 ...EBIT Margin. -2872.56%. -43865.44%. -. -. -. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Aditxt, Inc. (ADTX). See many years of revenue, …

Aditxt Inc. stock performance at a glance. Check Aditxt Inc. ’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Apr 20, 2023 · Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ...

Frequently Asked Questions for Aditxt, Inc. Shareholders Aditxt stock is traded on the Nasdaq Capital Market exchange under the ticker symbol ADTX, and its common stock CUSIP number is 007025505. Aditxt’s initial public offering (IPO) occurred on July 2, 2020. Vstock Transfer, LLC is Aditxt’s transfer agent. Vstock Transfer, LLC18 LafayetteThe stock surged over 500% Thursday, on which it once again was halted, resumed trading, and was then halted again. Aditxt is a low-float stock and is trading higher on abnormally-high volume. According to Benzinga Pro, the stock experienced above-average trading volume of 1.14 million shares on Thursday compared to its average …

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Aditxt, Inc. : Industry and sector chart comparison Stock Aditxt, Inc. | ADTX | US0070256047 | Nasdaq.Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and …Aditxt stock price has plummeted: avoid at all cost. Aditxt (NASDAQ: ADTX) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year.Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and …

Aditxt stock price from Google Finance. We’ve looked before at Aditxt: “That something is to simply declare that what used to be 40 pieces of stock are now just the one. A one for 40 reverse share split: “Aditxt, Inc. (ADTX) will effect a one-for-forty (1-40) reverse split of its Common Stock. The reverse stock split will become effective ...

Aditxt to Present at the 13th Annual LD Micro Main Event Conference - PCG-Advisory Presentation on Tuesday December 15that 11:00am EST LOS …

RICHMOND, Va., August 31, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business. Update Webinar on April 14 th. Richmond, Virginia - April 5, 2022 - Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX) has entered into a revenue-sharing agreement with Cellvera, and certain of its affiliates. The agreement is designed …Aditxt Stock Performance. ADTX opened at $3.50 on Wednesday. Aditxt has a 12-month low of $3.27 and a 12-month high of $76.40. The stock has a fifty day moving average of $8.52 and a 200-day ...Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m. Eastern Time on August 18, 2023.Aditxt (NASDAQ:ADTX) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the market under Nasdaq ...

Aditxt (NASDAQ: ADTX) stock is listed, by some tickers, as being up 35% this morning. Which, following a 37% price rise on Friday – because such rises are cumulative – means a near 100% appreciation in ADTX in only two trading days. Which is pretty good really. Other tickers are showing that Aditxt stock is in fact up 6,750% this …All values updated annually at fiscal year end. Earnings Per Share -595.50. Sales 20.14. Tangible Book Value 47.38. Operating Profit -537.79. Working Capital 10.22. Long Term Liabilities 17.51 ... On April 3, 2023, Aditxt subsidiary, Pearsanta, Inc. (“Pearsanta”) submitted a bid to acquire substantially all of Lucira Health Inc.’s (“Lucira”) assets, which included Lucira Connect and FDA-approved at-home combination COVID-19 and flu tests. At the bankruptcy auction, which was held on April 6, 2023, Pearsanta was chosen as the ...Track Aditxt Inc (ADTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Aditxt to Implement 1-for-40 Reverse Stock Split Aug. 17: MT Aditxt, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 Aug. 14: CI Aditxt, Inc. Announces Resignation of Matthew Shatzkes as Chief Legal Officer, General Counsel and Corporate Secretary ...May 18, 2021. Shareholder Letter from Amro Albanna. STOCK QUOTE View All CHARTING View Full ChartAditxt, Inc. (ADTX) is a global innovation activation company that discovers, develops, and deploys technologies that monitor and modulate the immune system. The stock price, news, quote, history, and research reports of ADTX are available on Yahoo Finance. See the latest updates on its performance outlook, earnings date, dividend yield, and more.

Stock Quote; SEC Filings; Corporate Governance; Frequently Asked Questions; Media Room. News; Media Coverage; Interviews; Press Releases; Contact UsIf you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

Aditxt, Inc. ADTX shares rose 126.1% to $7.80 in pre-market trading. ... jumped 93% on Wednesday after the company effected a 1-for-10 reverse stock split for its Class A and Class B common stock.Aditxt, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise certain Series C warrants to purchase shares of the Company's common stock ...Stock analysis for Aditxt Inc (ADTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Stock Quote ChartingAditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m. Eastern …23.60. 24.00. 24.00. 950. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for ADTX stock on Yahoo Finance. View daily, weekly or monthly formats back to when Aditxt, Inc. stock was issued.Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other …

Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...

Certain Common Stock of Aditxt, Inc. are subject to a Lock-Up Agreement Ending on 24-JUL-2023. Jul. 23: CI Aditxt, Inc. announced that it has received $0.001 million in funding Jul. 10: CI Aditxt, Inc. announced that it has received $0.25 million in funding Jul. 02: CI

Aditxt, Inc., (NASDAQ: ADTX) (' Aditxt ' or the 'Company'), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces the formation of a U.S.-based wholly- owned subsidiary, Pearsanta, Inc. ('Pearsanta'), to accelerate the growth of Aditxt's second program, AditxtScore, through future strategic revenue and ...Find out all the key statistics for Aditxt, Inc. (ADTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...Aditxt reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always ...Dec 1, 2023 · According to 1 stock analyst, the 12-month stock price forecast for Aditxt stock is $61, which predicts an increase of 1,694.12%. On average, analysts rate Aditxt stock as a strong buy. Find out all the key statistics for Aditxt, Inc. (ADTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...Aditxt (NASDAQ: ADTX) stock is listed, by some tickers, as being up 35% this morning. Which, following a 37% price rise on Friday – because such rises are cumulative – means a near 100% appreciation in ADTX in only two trading days. Which is pretty good really. Other tickers are showing that Aditxt stock is in fact up 6,750% this …Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. ...Aditxt Inc (NASDAQ: ADTX) has experienced a decline in its stock price by -14.36 compared to its previous closing price of 3.97. However, the company has seen a fall of -6.34% in its stock price over the last five trading days. InvestorPlace reported 2023-11-30 that Aditxt (NASDAQ: ADTX ) stock is rocketing higher on Thursday despite […]

Aditxt, Inc. is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. According to data from Benzinga Pro, Aditxt shares are trading well below the stock's 50-day moving average …Dec 1, 2023 · Stock analysis for Aditxt Inc (ADTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Nov 30, 2023 · Aditxt stock price from Google Finance. As we can see that price rise went away again and rather rapidly at that. There’s also been the reverse stock split at Aditxt: “Aditxt (NASDAQ: ADTX) stock should rise 4,000% at the open. ADTX stock also rose 32% yesterday but these are two entirely and wholly different things. Aditxt’s monitoring service is based on a comprehensive evaluation of the immune response to the virus or vaccine. AditxtScore provides meaningful information to help understand one’s personal immune response to COVID and not just that of the population collectively. Learn more about what your results mean in this video. From the White ...Instagram:https://instagram. emqq holdingsbest futures to tradebetterment alternativesgm contract talks Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 Business Wire - Aug 17, 2023, 12:00PM Full archive of press releases ...The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Items 10 through 14 of the previously filed Annual Report on Form 10-K of Aditxt, Inc. (the “Company”) for the year ended December 31, 2022, filed with the Securities and Exchange Commission on April 17, 2023 (the “Original Form 10-K”), to include information previously omitted in ... uvyxishares core sandp us growth etf Aditxt, Inc. (ADTX) latest earnings report: revenue, EPS, surprise, history, news and analysis. allstate motorcycle quote Aditxt, Inc. is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops …Aditxt Inc ( ADTX) has risen Thursday morning, with the stock climbing 5.31% in pre-market trading to 10.32. ADTX's short-term technical score of 40 indicates that the stock has traded less bullishly over the last month than 60% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, the stock ranks higher ...Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate